Solve Therapeutics
Clinical trials sponsored by Solve Therapeutics, explained in plain language.
-
New drug SLV-154 enters human testing for multiple advanced cancers
Disease control Recruiting nowThis early-phase study tests a new drug called SLV-154 in about 70 people whose solid tumors (like head and neck, lung, breast, or ovarian cancer) have spread. The main goal is to find a safe dose and watch for side effects. Participants must have a confirmed diagnosis and be in …
Phase: PHASE1 • Sponsor: Solve Therapeutics • Aim: Disease control
Last updated May 17, 2026 11:34 UTC
-
New hope for advanced cancer: SLV-324 enters human testing
Disease control Recruiting nowThis early-phase study tests a new drug called SLV-324 in about 70 adults with metastatic solid tumors that have worsened after standard treatments. The main goal is to find the safest dose and check how the drug affects the body and tumors. This is not a cure, but aims to contro…
Phase: PHASE1 • Sponsor: Solve Therapeutics • Aim: Disease control
Last updated May 13, 2026 15:59 UTC